Part I – What part will new tech play in economic recovery?

Part I – What part will new tech play in economic recovery?

R-Zero Systems, a San Jose based company incorporated in April 2020, has developed UV-C (ultraviolet-C) portable units that can disinfect a room in minutes. Co-founders Ben Boyer and Eli Harris's vision is to expand the use of UV lights as...

Continue reading →

Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Siemens Healthineers (SHL.DE) announced that it would acquire Varian Medical Systems (VAR) on the 2nd of August 2020 for USD 16.4bn. Siemens will purchase all of Varian's shares for $177.50/share in cash; a 24% premium. The deal will be financed...

Continue reading →

Will smaller biotech companies challenge or replace the current cohort of Big Pharma?

Will smaller biotech companies challenge or replace the current cohort of Big Pharma?

The Financial Times released an article on 14 August 2020 highlighting the significant increase in healthcare IPOs of companies that are working towards a Covid-19 vaccine. According to Martin Steinbach, Head of EY’s IPO and listing services EMEIA, “2020’s initial...

Continue reading →

Now healthcare and technology are becoming increasingly intertwined, will this lead to a successful vaccine?

Now healthcare and technology are becoming increasingly intertwined, will this lead to a successful vaccine?

Soo Aleman, a researcher and physician at the Karolinska University Hospital in Stockholm, released a study on 29 June 2020 that showed that individuals who had been infected by SARS-CoV-2 either did not develop any antibodies or if they...

Continue reading →

Will the UK government consider CBD an investment opportunity and bring legislation up to date?

Will the UK government consider CBD an investment opportunity and bring legislation up to date?

Global Market Insights published a report in February 2020 on the cannabidiol (CBD) market, forecasting a global market value (in terms of revenues) of USD 89bn by 2026 up from $3bn in 2019; a striking 3,036% increase, which is...

Continue reading →

Old drugs plus SARS equals new INDs and M&A pressure wave

Old drugs plus SARS equals new INDs and M&A pressure wave

There is pressure for M&A and raised valuation multiples in the kinase inhibitor market. The University of California San Francisco (UCSF) conducted a research study in April 2020 that took existing and approved drugs and investigated their ability to stop...

Continue reading →

Saving the Care Home healthcare segment – Technology, M&A and the State

Saving the Care Home healthcare segment – Technology, M&A and the State

David Grabowski, a Harvard Medical School professor who specialises in healthcare policy, in an interview with Yahoo Finance in July 2020 spoke to the crisis of the US care home industry pre-Covid. Prior to the pandemic care home facilities...

Continue reading →

AI beats human diagnostics

AI beats human diagnostics

A team of researchers from Google Health, working closely with researchers from North America, published a report recently in JAMA Oncology that showcased how their Artificial Intelligence (AI) diagnostic systems outperformed general pathologists in determining the degree of advancement...

Continue reading →

Researchers say that our pain threshold can be linked to Neanderthal DNA

Researchers say that our pain threshold can be linked to Neanderthal DNA

Researchers from the Max Planck Institute for Evolutionary Anthropology (Germany) and the Karolinska Institutet (Sweden) say that our pain threshold can be linked to Neanderthal DNA. Neanderthals, or Homo neanderthalensis, lived in Eurasia up until 40,000 years ago. Current thinking...

Continue reading →

Trials of a vaccine and a new drug raise hopes of beating Covid-19

Trials of a vaccine and a new drug raise hopes of beating Covid-19

Oxford University published a paper in the Lancet on their trial of a Covid-19 vaccine on the 20th of July 2020. Even though Oxford University has been researching a vaccine since January 2020 and AstraZeneca (AZN.L) rushed to get...

Continue reading →